Related Experiment Video
Updated: Jan 9, 2026

09:40
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
3.1K
Functional dynamic modulation of colorectal cancer initiation and metastatic capacity by a novel MiR-7974 regulatory
Yu-Hao Liu1, Yi-Tung Chen2, Yu-Chang Chen3
1Department of Cell and Molecular Biology, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Biomedical Journal
|November 30, 2025
Summary
MicroRNA-7974 (miR-7974) promotes colorectal cancer (CRC) growth by suppressing cell cycle regulators but reduces metastasis by targeting MYO1E. Dynamic miR-7974 expression influences CRC progression and patient survival.
Area of Science:
- Molecular Biology
- Genomics
- Oncology
Background:
- Colorectal cancer (CRC) is a prevalent malignancy with high rates of metastasis and recurrence, necessitating novel therapeutic strategies.
- Advancements in omics data analysis have elucidated complex regulatory networks in tumorigenesis, offering new avenues for cancer therapy.
Purpose of the Study:
- To identify novel microRNAs (miRNAs) involved in colorectal cancer (CRC) progression.
- To investigate the regulatory network and functional roles of miR-7974 in CRC growth and metastasis.
Main Methods:
- Systematic transcriptomic analysis of CRC tissues and normal samples to identify differentially expressed miRNAs.
- RT-qPCR, cell-based assays, and xenograft models to assess miR-7974's function in tumor progression.
- RNA sequencing, reporter assays, and functional rescue experiments to delineate the miR-7974 regulatory network, focusing on CDKN1A and MYO1E.
Main Results:
- miR-7974 exhibits distinct expression patterns in CRC, with high levels in early stages and decreased abundance in later, metastatic stages.
- miR-7974 promotes CRC growth by downregulating CDKN1A and reduces migration/invasion by targeting MYO1E.
- miR-7974 represses epithelial-to-mesenchymal transition (EMT), maintaining a proliferative epithelial phenotype and correlating with favorable patient survival outcomes.
Conclusions:
- miR-7974 regulates EMT plasticity in CRC, promoting proliferation while suppressing metastatic potential.
- The dynamic expression of miR-7974 and its target gene regulation provide mechanistic insights into metastatic potential acquisition.
- miR-7974's functional effects on CRC growth and its prognostic significance highlight its role in cancer development and miRNome dynamics.
More Related Videos
Related Concept Videos
MicroRNAs
3.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs
23.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K

